SMS-Based Remote Symptom Monitoring for Patients With Plasma Cell Disorders

Mayo Clinic

Summary

This study evaluates whether daily SMS-based (text messages) symptom monitoring is feasible and acceptable in patients who are undergoing treatment for multiple myeloma (MM) or systemic light chain amyloidosis (AL), and whether it can help in early identification of symptoms that may require clinical attention.

Eligibility

Age range: 18+ years
Sex: All
Healthy volunteers: No

Detailed criteria

Inclusion Criteria: * Age \>= 18 years * Diagnosis of MM or AL based on IMWG diagnostic criteria * Planned to start a new treatment within 14 days (+/-7 days) * Able to provide written informed consent Exclusion Criteria: * Not able to give informed consent

Interventions

Other
Non-Interventional Study
Non-interventional study

Location

Mayo Clinic in Rochester
Rochester, Minnesota
507-538-1301

Summary

Eligibility

Interventions

Location

Conditions